GREENWICH BIOSCIENCES Trademark

Trademark Overview

On Thursday, May 26, 2016, a trademark application was filed for GREENWICH BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the GREENWICH BIOSCIENCES trademark a serial number of 87977676. The federal status of this trademark filing is REGISTERED as of Tuesday, February 19, 2019. This trademark is owned by GW Research Limited. The GREENWICH BIOSCIENCES trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Educational services, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, cancer treatment and cannabinoid medicines; instruction services in the field of pharmaceutical product development of medicines, cancer treatments and cannabinoid medicines

Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and new product design services relating thereto, all not involving cannabinoid medicines; chemical analysis not involving cannabinoid medicines; chemical research not involving cannabinoid medicines; research and development in the field of medicines, healthcare, and cancer treatment, not involving cannabinoid medicines; and Scientific and technological services, namely, scientific research, analysis, testing in the field of cannabinoid medicine development, and research and new product design services relating thereto, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more ...
greenwich biosciences

General Information

Serial Number87977676
Word MarkGREENWICH BIOSCIENCES
Filing DateThursday, May 26, 2016
Status700 - REGISTERED
Status DateTuesday, February 19, 2019
Registration Number5682224
Registration DateTuesday, February 19, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and ServicesEducational services, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, cancer treatment and cannabinoid medicines; instruction services in the field of pharmaceutical product development of medicines, cancer treatments and cannabinoid medicines
Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and ServicesScientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and new product design services relating thereto, all not involving cannabinoid medicines; chemical analysis not involving cannabinoid medicines; chemical research not involving cannabinoid medicines; research and development in the field of medicines, healthcare, and cancer treatment, not involving cannabinoid medicines; and Scientific and technological services, namely, scientific research, analysis, testing in the field of cannabinoid medicine development, and research and new product design services relating thereto, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical research involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research and development in the field of cannabinoid medicines involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, June 2, 2016
Primary Code041
First Use Anywhere DateWednesday, January 31, 2018
First Use In Commerce DateWednesday, January 31, 2018
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 2, 2016
Primary Code042
First Use Anywhere DateWednesday, January 31, 2018
First Use In Commerce DateWednesday, January 31, 2018

Trademark Owner History

Party NameGW PHARMA LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressCAMBRIDGE CB249BZ
GB
Party NameGW Research Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHiston, Cambridge CB249BZ
Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHiston, Cambridge CB249BZ
Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHiston, Cambridge CB249BZ

Trademark Events

Event DateEvent Description
Monday, February 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 28, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 29, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 19, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, January 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 16, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, January 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 16, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, January 16, 2019SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, December 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 11, 2018NON-FINAL ACTION E-MAILED
Monday, June 11, 2018SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 23, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, May 14, 2018USE AMENDMENT FILED
Wednesday, May 23, 2018DIVISIONAL PROCESSING COMPLETE
Monday, May 14, 2018DIVISIONAL REQUEST RECEIVED
Wednesday, May 23, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 14, 2018TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 14, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 14, 2017EXAMINER'S AMENDMENT ENTERED
Monday, August 14, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 14, 2017EXAMINERS AMENDMENT E-MAILED
Monday, August 14, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, July 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 7, 2017ASSIGNED TO LIE
Wednesday, July 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 17, 2017NON-FINAL ACTION E-MAILED
Friday, February 17, 2017NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2017ASSIGNED TO EXAMINER
Wednesday, January 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 24, 2017ASSIGNED TO LIE
Wednesday, January 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 1, 2016ATTORNEY REVIEW COMPLETED
Monday, August 15, 2016DIVISIONAL PROCESSING COMPLETE
Thursday, July 28, 2016DIVISIONAL REQUEST RECEIVED
Monday, August 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 10, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 28, 2016TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, July 5, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 5, 2016NON-FINAL ACTION E-MAILED
Tuesday, July 5, 2016NON-FINAL ACTION WRITTEN
Friday, June 24, 2016ASSIGNED TO EXAMINER
Thursday, June 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 30, 2016NEW APPLICATION ENTERED

Related Keywords

biosciences greenwich medicines cannabinoid involving product research services field development cancer scientific